Vistagen Therapeutics Inc Stock Performance
as on March 21, 2026 at 6:59 am IST
Day's High
$0.60$0.658.33%
Upside
52 Week's Low
52 Week's High
$0.43$5.14
28.33%
Downside
756.67%
Upside
Vistagen Therapeutics Inc share price movements today
- Previous Close
- $0.64
- Open
- $0.65
- Volume
- 515.5K
- Day's Low - High
- $0.60 - $0.65
- 52 Week Low - High
- $0.43 - $5.14
Vistagen Therapeutics Inc Historical Returns
- 1 Month Return
- + 10.57 %
- 3 Month Return
- -14.6 %
- 1 Year Return
- -78.17 %
- 3 Year Return
- -85.5 %
- 5 Year Return
- -99.08 %
Vistagen Therapeutics Inc Stock Fundamentals & Key Indicators
Check Vistagen Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$24.1M
EPS (TTM)
-1.7133
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-69.7M
Revenue (TTM)
789.0K
Profit Margin
0.00%
Return On Equity TTM
-101.55%
Vistagen Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Vistagen Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $24.1M | -99.08% | NA | 0.00% | |
| BUY | $41.4B | 125.13% | 133.41 | 8.45% | |
| BUY | $115.3B | 112.56% | 29.67 | 32.94% | |
| NA | $31.6B | NA | 111 | 5.37% | |
| BUY | $77.5B | 56.01% | 17.67 | 31.41% |
Stock Returns calculator for Vistagen Therapeutics Inc Stock including INR - Dollar returns
The Vistagen Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Vistagen Therapeutics Inc investment value today
Current value as on today
₹30,950
Returns
Returns from Vistagen Therapeutics Inc Stock
Dollar Returns*
₹9,445 (+9.44%)
Analyst Recommendation on Vistagen Therapeutics Inc Stock
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Vistagen Therapeutics Inc. Average target price of $0.97
Vistagen Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Vistagen Therapeutics Inc.
What analysts predicted
38.14%UPSIDE
Target Price
$0.97
Current Price
$0.6
Analyzed by
10 Analysts
Target
$0.97
Vistagen Therapeutics Inc target price $0.97, a slight upside of 38.14% compared to current price of $0.6. According to 10 analysts rating.
Vistagen Therapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for Vistagen Therapeutics Inc Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Vistagen Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Vistagen Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Vistagen Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Vistagen Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Vistagen Therapeutics Inc News & Key Events
Today's Timeline - 31 January
Sun, 05:05 AM
-Rosen Law Firm reminds Vistagen investors of March 16, 2026, lead plaintiff deadline in securities class action regarding misleading statements.
Sat, 06:42 PM
-Faruqi & Faruqi investigates claims against Vistagen following failed PALISADE-3 trial results, reminding investors of the March 16, 2026 deadline.
Insights on Vistagen Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 4 quarters, -15.0K → 303.0K (in $), with an average increase of 42.1% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -19.41M → -18.89M (in $), with an average increase of 2.7% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Vistagen Therapeutics Inc has experienced a drawdown of -85.5%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 76.9%
- NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 11.3% return, outperforming this stock by 89.5%
NEGATIVE IMPACTPrice Dip
In the last 6 months, VTGN stock has moved down by -82.3%
About Vistagen Therapeutics Inc
| Organisation | Vistagen Therapeutics Inc |
| Headquarters | 343 Allerton Avenue, South San Francisco, CA, United States, 94080 |
| Industry | Health Technology |
| CEO | Mr. Shawn K. Singh J.D. |
| E-voting on shares | Click here to vote |
Key Management of Vistagen Therapeutics Inc
Name | Title |
|---|---|
Mr. Shawn K. Singh J.D. | President, CEO & Director |
Mr. Reid G. Adler Esq., J.D. | Chief Legal Officer |
Mr. Nick B. Tressler M.B.A. | CFO, Principal Financial & Accounting Officer and Treasurer |
Ms. Elissa Cote | Chief Corporate Development Officer |
Dr. Mark J. Ginski Ph.D. | Senior VP and Head of Chemistry, Manufacturing & Controls |
Mr. Joshua S. Prince M.B.A. | Chief Operating Officer |
Mr. Mark Adrian McPartland | Senior Vice President of Investor Relations |
Ms. Michelle Peters Wellington | Vice President of Communications |
Ms. Trisha Fitzmaurice | Senior Vice President of Human Resources |
Dr. Allen Easley Cato III, M.D., Ph.D. | Senior Vice President of Integrated Drug Development |
FAQs
What is Vistagen Therapeutics Inc share price today?
Vistagen Therapeutics Inc share price today is $0.6 as on at the close of the market. Vistagen Therapeutics Inc share today touched a day high of $0.65 and a low of $0.6.
What is the 52 week high and 52 week low for Vistagen Therapeutics Inc share?
Vistagen Therapeutics Inc share touched a 52 week high of $5.14 on and a 52 week low of $0.43 on . Vistagen Therapeutics Inc stock price today i.e. is closed at $0.6,which is 88.33% down from its 52 week high and 39.53% up from its 52 week low.
What is Vistagen Therapeutics Inc's market capitalisation today?
Vistagen Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Vistagen Therapeutics Inc Stock (VTGN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Vistagen Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vistagen Therapeutics Inc Shares that will get you 2.5000 shares as per Vistagen Therapeutics Inc share price of $0.6 per share as on March 21, 2026 at 1:29 am IST.
What is the minimum amount required to buy Vistagen Therapeutics Inc Stock (VTGN) from India?
Indian investors can start investing in Vistagen Therapeutics Inc (VTGN) shares with as little as ₹93.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Vistagen Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Vistagen Therapeutics Inc share’s latest price of $0.6 as on March 21, 2026 at 1:29 am IST, you will get 16.6667 shares of Vistagen Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Vistagen Therapeutics Inc has given to Indian investors in the last 5 years?
Vistagen Therapeutics Inc stock has given -99.08% share price returns and 28.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?